In-silico natural product database mining for novel neuropilin-1 inhibitors: molecular docking, molecular dynamics and binding energy computations

References

• Szent-Gyoergyi A. Cell-division and cancer. Science. 1965;149:34–37. doi:10.1126/science.149.3679.34.
   PubMed Web of Science ®Google Scholar
• Ma X, Yu H. Global burden of cancer. Yale J Biol Med. 2006;79:85–94.
   PubMedGoogle Scholar
• Mortality GBD. Causes of death, C. global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459–1544. doi:10.1016/S0140-6736(16)31012-1.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2021;71:209–249. doi:10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Pecorelli S, Benedet JL, Creasman WT, et al. FIGO staging of gynecologic cancer. Int J Gynaecol Obstet. 1999;64:5–10. doi:10.1016/s0020-7292(98)00234-3.
   PubMed Web of Science ®Google Scholar
• Benjamin DJ, Xu A, Lythgoe MP, et al. Cancer drug approvals that displaced existing standard-of-care therapies, 2016-2021. JAMA Netw Open. 2022;5:e222265. doi:10.1001/jamanetworkopen.2022.2265.
   PubMed Web of Science ®Google Scholar
• Longley DB, Johnston PG. Molecular mechanisms of drug resistance. J Pathol. 2005;205:275–292. doi:10.1002/path.1706.
   PubMed Web of Science ®Google Scholar
• Shi F, Shang L, Yang LY, et al. Neuropilin-1 contributes to esophageal squamous cancer progression via promoting P65-dependent cell proliferation. Oncogene. 2018;37:935–943. doi:10.1038/onc.2017.399.
   PubMed Web of Science ®Google Scholar
• Luo M, Hou L, Li J, et al. VEGF/NRP-1 axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin. Cancer Lett. 2016;373:1–11. doi:10.1016/j.canlet.2016.01.010.
   PubMed Web of Science ®Google Scholar
• Hong TM, Chen YL, Wu YY, et al. Targeting neuropilin 1 as an antitumor strategy in lung cancer. Clin Cancer Res. 2007;13:4759–4768. doi:10.1158/1078-0432.CCR-07-0001.
   PubMed Web of Science ®Google Scholar
• Li LH, Jiang X, Zhang Q, et al. Molecular targeted therapy for the treatment of gastric cancer. J Exp Clin Cancer Res. 2016;35:1–12. doi:10.1186/s13046-015-0276-9.
   PubMed Web of Science ®Google Scholar
• Hang C, Yan HS, Gong C, et al. MicroRNA-9 inhibits gastric cancer cell proliferation and migration by targeting neuropilin–1. Exp Ther Med. 2019;18:2524–2530. doi:10.3892/etm.2019.7841.
   PubMed Web of Science ®Google Scholar
• Zhou R, Curry JM, Roy LD, et al. A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis. Oncogene. 2016;35:5608–5618. doi:10.1038/onc.2015.516.
   PubMed Web of Science ®Google Scholar
• Hendricks C, Dubail J, Brohee L, et al. A novel physiological glycosaminoglycan-deficient splice variant of neuropilin-1 Is anti-tumorigenic In vitro and In vivo. PLoS One. 2016;11:e0165153. doi:10.1371/journal.pone.0165153.
   PubMed Web of Science ®Google Scholar
• Al-Shareef H, Hiraoka SI, Tanaka N, et al. Use of NRP1, a novel biomarker, along with VEGF-C, VEGFR-3, CCR7 and SEMA3E, to predict lymph node metastasis in squamous cell carcinoma of the tongue. Oncol Rep. 2016;36:2444–2454. doi:10.3892/or.2016.5116.
   PubMed Web of Science ®Google Scholar
• Jimenez-Hernandez LE, Vazquez-Santillan K, Castro-Oropeza R, et al. NRP1-positive lung cancer cells possess tumor-initiating properties. Oncol Rep. 2017;39:349–357. doi:10.3892/or.2017.6089.
   PubMed Web of Science ®Google Scholar
• Soker S, Takashima S, Miao HQ, et al. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 1998;92:735–745. doi:10.1016/S0092-8674(00)81402-6.
   PubMed Web of Science ®Google Scholar
• Yoshida A, Shimizu A, Asano H, et al. VEGF-A/NRP1 stimulates GIPC1 and Syx complex formation to promote RhoA activation and proliferation in skin cancer cells. Biol Open. 2015;4:1063–1076. doi:10.1242/bio.010918.
   PubMed Web of Science ®Google Scholar
• Sun L, Chen B, Jiang R, et al. Resveratrol inhibits lung cancer growth by suppressing M2-like polarization of tumor associated macrophages. Cell Immunol. 2017;311:86–93. doi:10.1016/j.cellimm.2016.11.002.
   PubMed Web of Science ®Google Scholar
• Liu SD, Zhong LP, He J, et al. Targeting neuropilin-1 interactions is a promising anti-tumor strategy. Chin Med J. 2021;134:508–517. doi:10.1097/CM9.0000000000001200.
   Web of Science ®Google Scholar
• Chuckran CA, Liu C, Bruno TC, et al. Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy. J Immunother Cancer. 2020;8:e000967. doi:10.1136/jitc-2020-000967.
   PubMed Web of Science ®Google Scholar
• Harvey AL, Clark RL, Mackay SP, et al. Current strategies for drug discovery through natural products. Expert Opin Drug Discov. 2010;5:559–568. doi:10.1517/17460441.2010.488263.
   PubMed Web of Science ®Google Scholar
• Harvey AL. Natural products in drug discovery. Drug Discov Today. 2008;13:894–901. doi:10.1016/j.drudis.2008.07.004.
   PubMed Web of Science ®Google Scholar
• Patridge E, Gareiss P, Kinch MS, et al. An analysis of FDA-approved drugs: natural products and their derivatives. Drug Discov Today. 2016;21:204–207. doi:10.1016/j.drudis.2015.01.009.
   PubMed Web of Science ®Google Scholar
• Zeng X, Zhang P, He W, et al. NPASS: natural product activity and species source database for natural product research, discovery and tool development. Nucleic Acids Res. 2018;46:D1217–D1222. doi:10.1093/nar/gkx1026.
   PubMed Web of Science ®Google Scholar
• Mota F, Fotinou C, Rana RR, et al. Architecture and hydration of the arginine-binding site of neuropilin-1. FEBS J. 2018;285:1290–1304. doi:10.1111/febs.14405.
   PubMed Web of Science ®Google Scholar
• Gordon JC, Myers JB, Folta T, et al. H++: a server for estimating pKas and adding missing hydrogens to macromolecules. Nucleic Acids Res. 2005;33:W368–W371. doi:10.1093/nar/gki464.
   PubMed Web of Science ®Google Scholar
• Heller SR, McNaught A, Pletnev I, et al. Inchi, the IUPAC international chemical identifier. J Cheminformatics. 2015;7:23, doi:10.1186/s13321-015-0068-4.
   PubMed Web of Science ®Google Scholar
• OMEGA. 2.5.1.4; openeye scientific software. Santa Fe, NM, USA, 2013.
   Google Scholar
• Hawkins PC, Skillman AG, Warren GL, et al. Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database. J Chem Inf Model. 2010;50:572–584. doi:10.1021/ci100031x.
   PubMed Web of Science ®Google Scholar
• SZYBKI. 1.9.0.3, openeye scientific software. Santa Fe, NM, USA, 2016.
   Google Scholar
• Halgren TA. MMFF VI. MMFF VI. MMFF94s option for energy minimization studies. J Comput Chem. 1999;20:720–729. doi:10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X.
   PubMed Web of Science ®Google Scholar
• QUACPAC. 1.7.0.2; openeye scientific software. Santa Fe, NM, USA, 2016.
   Google Scholar
• Gasteiger J, Marsili M. Iterative partial equalization of orbital electronegativity—a rapid access to atomic charges. Tetrahedron. 1980;36:3219–3228. doi:10.1016/0040-4020(80)80168-2.
   Web of Science ®Google Scholar
• Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2009;31:455–461. doi:10.1002/jcc.21334.
   Web of Science ®Google Scholar
• Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem. 2009;30:2785–2791. doi:10.1002/jcc.21256.
   PubMed Web of Science ®Google Scholar
• Cetin A. In silico studies on stilbenolignan analogues as SARS-CoV-2 Mpro inhibitors. Chem Phys Lett. 2021;771:138563, doi:10.1016/j.cplett.2021.138563.
   PubMed Web of Science ®Google Scholar
• Cetin A, Bursal E, Türkan F. 2-methylindole analogs as cholinesterases and glutathione S-transferase inhibitors: Synthesis, biological evaluation, molecular docking, and pharmacokinetic studies. Arab J Chem. 2021;14:103449, doi:https://doi.org/10.1016/j.arabjc.2021.103449.
   Web of Science ®Google Scholar
• Cetin A, Donmez A, Dalar A, et al. Tetra-substituted pyrazole analogues: synthesis, molecular docking, ADMET prediction, antioxidant and pancreatic lipase inhibitory activities. Med Chem Res. 2023;32:189–204. doi:10.1007/s00044-022-03005-7.
   Web of Science ®Google Scholar
• Case DAB, Cerutti DS, Cheatham TE, et al. AMBER 2016. San Francisco, USA: University of California.
   Google Scholar
• Ibrahim MAA, Badr EAA, Abdelrahman AHM, et al. In Silico targeting human multidrug transporter ABCG2 in breast cancer: Database screening, molecular docking, and molecular dynamics study. Mol Inform. 2022;41:2060039. doi:10.1002/minf.202060039.
   PubMed Web of Science ®Google Scholar
• Ibrahim MAA, Badr EAA, Abdelrahman AHM, et al. Prospective drug candidates as human multidrug transporter ABCG2 inhibitors: An in silico drug discovery study. Cell Biochem Biophys. 2021;79:189–200. doi:10.1007/s12013-021-00985-y.
   PubMed Web of Science ®Google Scholar
• Ibrahim MAA, Abdelrahman AHM, Badr EAA, et al. Naturally occurring plant-based anticancerous candidates as prospective ABCG2 inhibitors: an in silico drug discovery study. Mol Divers. 2022: 3255–3277. doi:10.1007/s11030-022-10389-6.
   PubMed Web of Science ®Google Scholar
• Ibrahim MAA, Abdeljawaad KAA, Abdelrahman AHM, et al. Non-β-Lactam allosteric inhibitors target methicillin-resistant staphylococcus aureus: An In silico drug discovery study. Antibiotics (Basel). 2021;10:934–956. doi:10.3390/antibiotics10080934.
   PubMed Web of Science ®Google Scholar
• Ibrahim MAA, Abdelrahman AHM, Jaragh-Alhadad LA, et al. Exploring toxins for hunting SARS-CoV-2 main protease inhibitors: molecular docking, molecular dynamics, pharmacokinetic properties, and reactome study. Pharmaceuticals. 2022;15:153. doi:10.3390/ph15020153.
   Web of Science ®Google Scholar
• Wang J, Wolf RM, Caldwell JW, et al. Development and testing of a general amber force field. J Comput Chem. 2004;25:1157–1174. doi:10.1002/jcc.20035.
   PubMed Web of Science ®Google Scholar
• Maier JA, Martinez C, Kasavajhala K, et al. ff14SB: Ff14sb: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput. 2015;11:3696–3713. doi:10.1021/acs.jctc.5b00255.
   PubMed Web of Science ®Google Scholar
• Jakalian A, Jack DB, Bayly CI. Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. Parameterization and Validation J Comput Chem. 2002;23:1623–1641. doi:10.1002/jcc.10128.
   PubMed Web of Science ®Google Scholar
• Roux B, Simonson T. Implicit solvent models. Biophys Chem. 1999;78:1–20. doi:10.1016/S0301-4622(98)00226-9.
   PubMed Web of Science ®Google Scholar
• Bayly CI, Cieplak P, Cornell WD, et al. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model. J Phys Chem. 1993;97:10269–10280. doi:10.1021/j100142a004.
   Web of Science ®Google Scholar
• Frisch MJ, Trucks GW, Schlegel HB, et al. Gaussian 09, revision E01; Gaussian09, Gaussian Inc. Wallingford, CT, USA: pn; 2009.
   Google Scholar
• Jorgensen WL, Chandrasekhar J, Madura JD, et al. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79:926–935. doi:10.1063/1.445869.
   Web of Science ®Google Scholar
• Darden T, York D, Pedersen L. Particle mesh Ewald: AnN⋅log(N) method for Ewald sums in large systems. J Chem Phys. 1993;98:10089–10092. doi:10.1063/1.464397.
   Web of Science ®Google Scholar
• Berendsen HJC, Postma JPM, Vangunsteren WF, et al. Molecular dynamics with coupling to an external bath. J Chem Phys. 1984;81:3684–3690. doi:10.1063/1.448118.
   Web of Science ®Google Scholar
• Izaguirre JA, Catarello DP, Wozniak JM, et al. Langevin stabilization of molecular dynamics. J Chem Phys. 2001;114:2090–2098. doi:10.1063/1.1332996.
   Web of Science ®Google Scholar
• Miyamoto S, Kollman PA. Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models. J Comput Chem. 1992;13:952–962. doi:10.1002/jcc.540130805.
   Web of Science ®Google Scholar
• Dassault Systèmes. BIOVIA, discovery studio visualize, version 2019; dassault systèmes: San Diego, CA, USA, 2019.
   Google Scholar
• Massova I, Kollman PA. Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding. Perspect Drug Discov. 2000;18:113–135. doi:10.1023/A:1008763014207.
   Google Scholar
• Onufriev A, Bashford D, Case DA. Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins. 2004;55:383–394. doi:10.1002/prot.20033.
   PubMed Web of Science ®Google Scholar
• Hou T, Wang J, Li Y, et al. Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking. II. The accuracy of ranking poses generated from docking. J Comput Chem. 2011;32:866–877. doi:10.1002/jcc.21666.
   PubMed Web of Science ®Google Scholar
• Wang E, Sun H, Wang J, et al. End-point binding free energy calculation with MM/PBSA and MM/GBSA: Strategies and applications in drug design. Chem Rev. 2019;119:9478–9508. doi:10.1021/acs.chemrev.9b00055.
   PubMed Web of Science ®Google Scholar
• Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717, doi:10.1038/srep42717.
   PubMed Web of Science ®Google Scholar
• Pires DE, Blundell TL, Ascher DB. pkCSM: Pkcsm: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015;58:4066–4072. doi:10.1021/acs.jmedchem.5b00104.
   PubMed Web of Science ®Google Scholar
• Kim MS, Oh KS, Lee JH, et al. Kamolonol suppresses angiotensin II-induced stress fiber formation and cellular hypertrophy through inhibition of Rho-associated kinase 2 activity. Biochem Biophys Res Commun. 2013;438:318–323. doi:10.1016/j.bbrc.2013.07.069.
   PubMed Web of Science ®Google Scholar
• Dastan D, Salehi P, Reza Gohari A, et al. Disesquiterpene and sesquiterpene coumarins from Ferula pseudalliacea, and determination of their absolute configurations. Phytochemistry. 2012;78:170–178. doi:10.1016/j.phytochem.2012.02.016.
   PubMed Web of Science ®Google Scholar
• Dixit D, Reddy CRK, Trivedi MH, et al. Non-targeted metabolomics approach to assess the brown marine macroalga Dictyota dichotoma as a functional food using liquid chromatography with mass spectrometry. Sep Sci Plus. 2020;3:140–149. doi:10.1002/sscp.201900109.
   Web of Science ®Google Scholar
• Kerrigan JE. Molecular dynamics simulations in drug design. In: Kortagere S, editor. silico models for drug discovery. Totowa, NJ: Humana Press; 2013. p. 95–113.
   Google Scholar
• De Vivo M, Masetti M, Bottegoni G, et al. Role of molecular dynamics and related methods in drug discovery. J Med Chem. 2016;59:4035–4061. doi:10.1021/acs.jmedchem.5b01684.
   PubMed Web of Science ®Google Scholar
• Jarvis A, Allerston CK, Jia H, et al. Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interaction. J Med Chem. 2010;53:2215–2226. doi:10.1021/jm901755g.
   PubMed Web of Science ®Google Scholar